News and updates
Novartis Issues Voluntary Nationwide Recall of One Lot of Sandimmune® Oral Solution Due to Crystallization
Novartis is conducting a voluntary nationwide recall at the consumer level of one lot of its Sandimmune® Oral Solution (cyclosporine oral solution, USP), 100 mg/mL in the US due to
CDC Health Advisory: Increased RSV Activity
The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to notify clinicians and caregivers about increases in respiratory syncytial virus (RSV) activity
FDA Approves First Oral Antiviral for Treatment of COVID-19 in Adults
Today, the U.S. Food and Drug Administration approved the oral antiviral Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate COVID-19 in adults who
All Opioid Pain Medicines: FDA Updates Prescribing Information
Issue The U.S. Food & Drug Administration (FDA) is requiring several updates to the prescribing information for both immediate-release (IR) and extended release/long acting (ER/LA) opioid pain medicines. This includes stating for all
Potential Risk of Exposure to Toxic Compounds – Hemodialysis and Peritoneal Dialysis Systems
The U.S. Food and Drug Administration (FDA) is continuing to evaluate the potential risk of exposure to toxic compounds when using dialysis systems. On May 6, 2022, the FDA issued
Update: Reduce the Risk for Medical Device Misconnections
Today, the U.S. Food and Drug Administration (FDA) added a new case study to its “Examples of Medical Device Misconnections” webpage. The webpage describes device misconnections based on reports of
Subscribe to our Newsletter